Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385157076> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4385157076 endingPage "6" @default.
- W4385157076 startingPage "1" @default.
- W4385157076 abstract "Abstract OBJECTIVE To determine the pharmacokinetic parameters of a high-concentration buprenorphine formulation after a single SC dose in American flamingos ( Phoenicopterus ruber ). ANIMALS 6 healthy adult American flamingos (3 males and 3 females). METHODS A single dose of high-concentration buprenorphine (1.8 mg/kg) was administered SC to all birds. Blood samples were collected at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 48, 72, and 96 hours after drug administration between October 14 and October 18, 2022. Plasma buprenorphine concentrations were determined by liquid chromatography-tandem mass spectrometry and a noncompartmental analysis was used to determine pharmacokinetic parameters. RESULTS Mean ± SD peak plasma drug concentration (C max ) was 195.1 ± 187.4 ng/mL, the mean time to peak plasma concentration (T max ) was 0.32 ± 0.31 hours, the mean area under the concentration-vs-time curve from time 0 to the last measured concentration (AUC 0–last ) was 881.4 ± 205.4 ng/mL, and mean terminal half-life (t 1/2 ) was 12.6 ± 3.86 hours. Mean plasma buprenorphine concentrations were >1 ng/mL for at least 48 hours after drug administration. No clinically significant adverse effects were observed. CLINICAL RELEVANCE High-concentration buprenorphine dosed at 1.8 mg/kg SC in American flamingos rapidly exceeded plasma drug concentrations reported to have analgesic effects in other avian species and maintained these levels for extended periods. Sedative effects were similar to those reported for other species. Additional studies are needed to evaluate the clinical efficacy of high-concentration buprenorphine at this dose in American flamingos." @default.
- W4385157076 created "2023-07-24" @default.
- W4385157076 creator A5037555094 @default.
- W4385157076 creator A5037966353 @default.
- W4385157076 creator A5053235229 @default.
- W4385157076 creator A5070830503 @default.
- W4385157076 creator A5076568290 @default.
- W4385157076 date "2023-07-25" @default.
- W4385157076 modified "2023-10-05" @default.
- W4385157076 title "High-concentration buprenorphine exceeds target plasma concentrations for extended periods following subcutaneous administration in American flamingos (Phoenicopterus ruber)" @default.
- W4385157076 doi "https://doi.org/10.2460/ajvr.23.05.0111" @default.
- W4385157076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37481252" @default.
- W4385157076 hasPublicationYear "2023" @default.
- W4385157076 type Work @default.
- W4385157076 citedByCount "0" @default.
- W4385157076 crossrefType "journal-article" @default.
- W4385157076 hasAuthorship W4385157076A5037555094 @default.
- W4385157076 hasAuthorship W4385157076A5037966353 @default.
- W4385157076 hasAuthorship W4385157076A5053235229 @default.
- W4385157076 hasAuthorship W4385157076A5070830503 @default.
- W4385157076 hasAuthorship W4385157076A5076568290 @default.
- W4385157076 hasBestOaLocation W43851570761 @default.
- W4385157076 hasConcept C112705442 @default.
- W4385157076 hasConcept C126322002 @default.
- W4385157076 hasConcept C140793950 @default.
- W4385157076 hasConcept C170493617 @default.
- W4385157076 hasConcept C185592680 @default.
- W4385157076 hasConcept C2777602617 @default.
- W4385157076 hasConcept C2778949969 @default.
- W4385157076 hasConcept C2780820201 @default.
- W4385157076 hasConcept C2781063702 @default.
- W4385157076 hasConcept C3020079912 @default.
- W4385157076 hasConcept C42219234 @default.
- W4385157076 hasConcept C71924100 @default.
- W4385157076 hasConcept C86803240 @default.
- W4385157076 hasConcept C98274493 @default.
- W4385157076 hasConceptScore W4385157076C112705442 @default.
- W4385157076 hasConceptScore W4385157076C126322002 @default.
- W4385157076 hasConceptScore W4385157076C140793950 @default.
- W4385157076 hasConceptScore W4385157076C170493617 @default.
- W4385157076 hasConceptScore W4385157076C185592680 @default.
- W4385157076 hasConceptScore W4385157076C2777602617 @default.
- W4385157076 hasConceptScore W4385157076C2778949969 @default.
- W4385157076 hasConceptScore W4385157076C2780820201 @default.
- W4385157076 hasConceptScore W4385157076C2781063702 @default.
- W4385157076 hasConceptScore W4385157076C3020079912 @default.
- W4385157076 hasConceptScore W4385157076C42219234 @default.
- W4385157076 hasConceptScore W4385157076C71924100 @default.
- W4385157076 hasConceptScore W4385157076C86803240 @default.
- W4385157076 hasConceptScore W4385157076C98274493 @default.
- W4385157076 hasLocation W43851570761 @default.
- W4385157076 hasLocation W43851570762 @default.
- W4385157076 hasOpenAccess W4385157076 @default.
- W4385157076 hasPrimaryLocation W43851570761 @default.
- W4385157076 hasRelatedWork W1807873557 @default.
- W4385157076 hasRelatedWork W1964759623 @default.
- W4385157076 hasRelatedWork W2030105938 @default.
- W4385157076 hasRelatedWork W2045564308 @default.
- W4385157076 hasRelatedWork W2063041576 @default.
- W4385157076 hasRelatedWork W2083640028 @default.
- W4385157076 hasRelatedWork W2362895824 @default.
- W4385157076 hasRelatedWork W2374724226 @default.
- W4385157076 hasRelatedWork W2410032012 @default.
- W4385157076 hasRelatedWork W2429943234 @default.
- W4385157076 isParatext "false" @default.
- W4385157076 isRetracted "false" @default.
- W4385157076 workType "article" @default.